Stocks

Asia-Pacific market

Investors weighed the risks associated with the Omicron COVID variant. Hence, Thursday’s Asian markets were mixed.

In Japan, the Nikkei 225 fell 0.47 percent to 28,725.47. Meanwhile, the Topix index fell 0.57 percent to 1,990.79.

The ASX 200 in Australia fell 0.28 percent to 7,384.50, with most sectors closing lower. 

The subindices for energy and materials fell 1.09 percent and 0.51 percent, respectively. Rio Tinto and BHP’s shares fell 0.94 percent and 1.2 percent, respectively.

South Korean stocks rose, with the benchmark Kospi up 0.93 percent to 3,029.57 and the Kosdaq up 1.67 percent to 1,022.87.

Chinese mainland stocks rose as well. The Shanghai composite increased by 0.98 percent to 3,673.04, while the Shenzhen component increased by 1.23 percent to 15,147.87. Hong Kong stocks rose as well, with the main Hang Seng index rising 1.08 percent to 24,254.86 and the tech-focused Hang Seng Tech index rising 2.23 percent to 6,103.16.

Related Post

Suncity shares have been halted pending an announcement regarding a possible loan default, according to Reuters, citing a company statement. According to the news agency, authorities arrested Suncity’s CEO last month for alleged involvement in cross-border gambling.

The Hong Kong-listed shares of major Chinese technology companies rose. Alibaba gained 2.32 percent, Baidu gained 1.52 percent. Moreover, Meituan gained 0.73 percent, and Tencent gained 1.2 percent.

India’s, Indonesia’s, and Singapore’s major indices rose Thursday afternoon. The major averages in the United States gained for the third day in a row while European shares fell.

Omicron variant

After a strong run in the previous two days, equities are taking a breather, with European shares closing lower amid concerns about the need for a new round of currency restrictions.

Investors are paying close attention to the Omicron COVID variant, which has roiled markets recently.

According to the World Health Organization, the variant could alter the course of the pandemic. Scientists around the world are scrambling to figure out how contagious and lethal Omicron is, as well as how effective existing vaccines would be against the virus. Meanwhile, Pfizer’s CEO stated that a fourth COVID-19 shot might become a necessity soon. It came after preliminary research revealed that the Omicron variant could undermine protective antibodies generated by the vaccine developed by the company in collaboration with BioNTech.

Recent Posts

Altcoins: Innovation and Investment Strategies

Cryptocurrencies have evolved beyond Bitcoin, giving rise to a new wave of digital assets known as altcoins. These alternative coins…

2 hours ago

Sweden Faces a 0.1% GDP Slump Amid Economic Woes

Key Points Sweden's economy contracted by 0.1% in Q1 2024, defying the expected 0.2% growth. March saw a 0.4% drop…

4 hours ago

Bitcoin at $62,528: Analysts Predict $210K by 2025

Key Points Bitcoin recently reported at $62,528, with a historical peak near $73,000. Estimates range from $70,000 by March to…

5 hours ago

The S&P 500 Ends Downturn, Up 2.7% This Week

Key Points: S&P 500 achieved its best weekly performance since November, rising 2.7% and reversing previous downturns. 80% of S&P…

5 hours ago

EUR/USD Climbs to 1.0710 Amid Dollar Weakness

Key Points EUR/USD is trading at 1.0710, boosted by a dip in the US Dollar Index below 106.00. Fed is…

6 hours ago

Oil Prices Drop: Brent at $88.55, WTI at $83.01

Key Points Oil prices declined as Brent crude and WTI futures fell, erasing gains from the previous Friday. Israel-Hamas talks…

7 hours ago

This website uses cookies.